Literature DB >> 21775844

Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.

Darcy F Phelan1, John K Boitnott, Douglas P Clark, Lisa C Dubay, Patti E Gravitt.   

Abstract

OBJECTIVE: To estimate time trends of actual provider use of human papillomavirus (HPV) testing in cervical cancer screening by using laboratory and administrative data from the Johns Hopkins Hospital Division of Cytopathology in Baltimore, Maryland.
METHODS: In this ecologic trend study, we analyzed 178,510 Pap specimen records and 12,221 HPV tests among 85,048 patients from 2001 to 2007. Monthly frequencies and proportions of HPV reflex testing and HPV cotesting with Pap (stratified by patient ages 30 and older and 18-29 years) were calculated. Time trends of monthly HPV testing proportions were analyzed using joinpoint regression methods.
RESULTS: From April 2002, when the American Society for Colposcopy and Cervical Pathology added HPV reflex testing to its guidelines, to December 2007, the monthly the proportion of reflex testing was 95.8%. From February 2004, when the society added HPV cotesting with Pap among women aged 30 years or older to its guidelines, to December 2007, the overall proportion HPV cotesting with Pap among patients aged 30 years or older was 7.8% (compared with 4.9% among patients 18-29 years [P<.01]). The highest proportion of HPV cotesting among women aged 30 years or older, 15%, was observed in September 2006, and the trend later plateaued around 13%. The monthly proportions of HPV reflex testing and cotesting with Pap changed significantly over time.
CONCLUSION: These data reveal that a small percentage of women aged 30 years or older received HPV cotesting with Pap, thus identifying a significant opportunity for providers to improve patient care in cervical cancer prevention. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2011        PMID: 21775844      PMCID: PMC4763923          DOI: 10.1097/AOG.0b013e3182253c33

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Improving the Utilization of Human Papillomavirus and Cervical Cytology Co-testing for Cervical Cancer Screening in an Obstetrics and Gynecology Resident Clinic.

Authors:  Kurt Yoshino; Maxine Karimoto; Christina Marzo; Bliss Kaneshiro; Mark Hiraoka
Journal:  Hawaii J Med Public Health       Date:  2015-08

2.  Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians.

Authors:  Maria Syl D de la Cruz; Alisa P Young; Mack T Ruffin
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

Review 3.  Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.

Authors:  M Saraiya; M Steben; M Watson; L Markowitz
Journal:  Prev Med       Date:  2013-02-08       Impact factor: 4.018

4.  Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Authors:  Michelle I Silver; Anne F Rositch; Darcy F Phelan-Emrick; Patti E Gravitt
Journal:  Cancer Causes Control       Date:  2017-11-09       Impact factor: 2.506

5.  Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.

Authors:  Jack Cuzick; Orrin Myers; William C Hunt; Debbie Saslow; Philip E Castle; Walter Kinney; Alan Waxman; Michael Robertson; Cosette M Wheeler
Journal:  Int J Cancer       Date:  2014-12-01       Impact factor: 7.396

6.  Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.

Authors:  Jin Qin; Shahram Shahangian; Mona Saraiya; Hunter Holt; Maribeth Gagnon; George F Sawaya
Journal:  Gynecol Oncol       Date:  2021-09-08       Impact factor: 5.482

7.  Communication practices about HPV testing among providers in Federally Qualified Health Centers.

Authors:  Lavinia Lin; Vicki B Benard; April Greek; Katherine B Roland; Nikki A Hawkins; Mona Saraiya
Journal:  Prev Med Rep       Date:  2015

8.  Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.

Authors:  Adana A M Llanos; Jennifer Tsui; David Rotter; Lindsey Toler; Antoinette M Stroup
Journal:  BMC Womens Health       Date:  2018-10-03       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.